Amezalpat

Overview

Amezalpat is the antagonist for PPARα with IC 50 of 58 nM. Amezalpat exhibits antineoplastic activity.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PPAR

Product Information

• Catalog No.: HY-172413
• CAS No.: 1616372-41-8
• Molecular Formula: C34H41N3O4
• Molecular Weight: 555.71
• Purity: 99.85%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 5 mg/mL (9.00 mM); Clear solution
• Availability: In-stock

Source

Original product source